PERAN MUTASI GEN ACY II TERHADAP PRODUKSI ANTIBIOTIK SEFALOSPORIN
Main Article Content
Abstract
The Roles of AcyII Gene Mutations for Production of Antibiotics Derived From Cephalosporin
Semisynthetic antibiotics cephalosporins are widely used to treat infectious diseases, especially those caused by gram-negative bacteria. Various types of semisynthetic antibiotics could be synthesized using 7-aminocephalosporanic acid (7-ACA) as the main raw material. 7-ACA is obtained by conversion of cephalosporin C, either chemically or enzymatically. Converting cephalosporin C to 7-ACA enzymatically in one step involves the cephalosporin acylase enzyme. Currently, all of cefalosporin acylase enzymes produced by wild-type microbes have only high activity on glutaryl-7-ACA as the main substrate. Genetic engineering of the encoding gene of cefalosporin acylase is required to obtain recombinant enzyme having high activity on cephalosporin C. In this paper, the engineering attempts made on acyII gene from Pseudomonas SE83 using directed mutagenesis, error prone PCR, and structural modeling are described.Â
Keywords: AcyII gene, cephalosporin, cephalosporin C acylase, enzyme activity, mutation
Â
ABSTRAK
Antibiotik sefalosporin semisintetik banyak digunakan untuk mengatasi penyakit infeksi, khususnya yang ditimbulkan oleh bakteri gram negatif. Berbagai jenis antibiotik semisintetk dapat disintesis menggunakan senyawa asam 7-aminosefalosporanat (7-ACA) sebagai bahan baku utamanya. Senyawa 7-ACA diperoleh melalui konversi sefalosporin C, baik yang dilakukan secara kimiawi maupun enzimatis. Konversi sefalosporin C menjadi 7-ACA secara enzimatis dalam satu langkah melibatkan enzim sefalosporin asilase. Hingga saat ini, seluruh enzim sefalosporin asilase yang dihasilkan oleh mikroba wild type hanya mempunyai aktifitas yang tinggi terhadap glutaryl-7-ACA. Rekayasa genetik terhadap gen pengkode enzim sefalosporin asilase diperlukan untuk memperoleh enzim rekombinan yang mempunyai aktifitas tinggi terhadap substrat sefalosporin C. Dalam ulasan ini diuraikan upaya-upaya rekayasa yang telah dilakukan terhadap gen acyII dari Pseudomonas SE83 menggunakan teknik mutasi terarah, error prone PCR, dan pemodelan struktur.
Kata kunci: Aktivitas enzim, gen acyII, mutasi, sefalosporin, sefalosporin C asilase
Â
Received: 14September 2017Â Â Â Â Accepted: 19 December 2017 Â Â Â Â Published: 30 December 2017Â Â
 ÂReceived: 14September 2017              Accepted: 19 December 2017           Published: 30 December 2017Â
ÂArticle Details
References
Aramori I, Fukagawa M, Tsumura M, Iwami M, Isogai T, Ono H, Ishitani Y, Kojo H, Kohsaka M, Ueda Y, Imenaka H (1991) Cloning and nucleotide sequencing of new glutaryl 7-ACA and cephalosporin C acylase genes from Pseudomonas strains. J Ferment Bioeng 72:232-243. doi: 10.1016/0922-338X(91)90155-A
Barber MS, Giesecke U, Reichert A, Minas W (2004) Industrial enzymatic production of cephalosporin-based b-lactams. Adv Biochem Engin/ Biotechnol 88:179-216. doi: 10.1007/b99261
Boeckel VTP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R (2014) Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742-750. doi: 10.1016/S1473-3099(14)70780-7
Coates ARM, Halls G, Hu Y (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163:184-194. doi: 10.1111/j.1476-5381.2011.01250.x
Gaurav K, Srivastava R, Sharma JG, Kundu S (2015) Statistical medium optimization for the production of cephalosporin-c acylase by Pseudomonas diminuta. J Biochem Technol 6:977-981
Golden E, Paterson R, Tie WJ, Anandan A, Flematti G, Molla G, Rosini E, Pollegioni L, Vrielink A (2013) Structure of a class III engineered cephalosporin acylase: comparisons with class I acylase and implications for differences in substrate specificity and catalytic activity. Biochem J 451: 217-226. doi: 10.1042/BJ20121715
Isdiyono BW, Hardianto D, Ivan FX (2017) Produksi rekombinan sefalosporin asilase sebagai biokatalis untuk produksi asam 7-aminosefalosporanat. J Bioteknol Biosains Indones 4:28-35. doi: 10.29122/jbbi.v4i1.2059
Kim Y, Yoon KH, Khang Y, Turley S, Hol WGJ (2000) The 2.0 Å crystal structure of cephalosporin acylase. Structure 8:1059-1068. doi: 10.1016/S0969-2126(00)00505-0
Li Q, Huang X, Zhu Y (2014) Evaluation of active designs of cephalosporin C acylase by molecular dynamics simulation and molecular docking. J Mol Model 20:2314. doi: 10.1007/s00894-014-2314-5
Mehta D, Sharma AK (2016) Cephalosporins: A review on imperative class of antibiotics. Inventi Rapid: Molecular Pharmacology 1:1-6
Nupura H, Asmita T, Sharath B, Asmita P (2008) Media optimization for the production of cephalosporin C acylase from a novel bacteria source: Alcaligenes xylosoxidans MTCC*491. Res J Biotechnol 3:16-21
Pollegioni L, Lorenzi S, Rosini E, Marcone GL, Molla G, Verga R, Cabri W, Pilone MS (2005) Evolution of an acylase active on cephalosporin C. Protein Sci 14:3064-3076. doi: 10.1110/ps.051671705
Pollegioni L, Rosini E, Molla G (2013) Cephalosporin C acylase: dream and(/or) reality. Appl Microbiol Biotechnol 97:2341-2355. doi: 10.1007/s00253-013-4741-0
Shin YC, Jeon JYJ, Jung KH, Park MR, Kim Y (2009) Cephalosporin C acylase mutant and method for preparing 7-ACA using same. United States Patent No US 7,592,168 B2
Tanomand A, Abeshov R, Farajnia S (2009) Determination of cephalosporin acylase activity by biological and colorimetric method in bacteria. Afr J Biotechnol 8:6697-6699
Vasait RD, Jobanputra AH (2013) Screening, isolation and identification of bacterial isolates having potential for bioconversion of cephalosporin C. Biotechnol India J 7:159-162
Wang Y, Yu H, Song W, An M, Zhang J, Luo H, Shen Z (2012) Overexpression of synthesized cephalosporin C acylase containing mutations in the substrate transport tunnel. J Biosci Bioeng 113:36-41. doi: 10.1016/j.jbiosc.2011.08.027
World Health Organization (2017) Critically important antimicrobials for human medicine. 5th rev. Geneva. Licence: CC BY-NC-SA 3.0 IGO
Xiao Y, Huo X, Qian Y, Zhang Y, Chen G, Ouyang P, Lin Z (2014) Engineering of CPC acylase using a facile pH indicator assay. J Ind Microbiol Biotechnol 41:1617-1625. doi: 10.1007/s10295-014-1501-9
Yu R (2013) Modeling and experimental analysis of cephalosporin C acylase and its mutant. Open Biotechnol J 7:30-37. doi: 10.2174/1874070701307010030
Zhang J, Yu H, Wang Y, Luo H, Shen Z (2014) Determination of the second autoproteolytic cleavage site of cephalosporin C acylase and the effect of deleting its flanking residues in the α-C-terminal region. J Biotechnol 184:138-145. doi: 10.1016/j.jbiotec.2014.05.016